Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phosphatidylethanolamine Binding Protein | 26 | 2022 | 37 | 6.740 |
Why?
|
Tumor Suppressor Proteins | 15 | 2012 | 279 | 2.970 |
Why?
|
Mitogen-Activated Protein Kinases | 14 | 2013 | 222 | 2.370 |
Why?
|
Insulysin | 24 | 2009 | 66 | 2.000 |
Why?
|
ErbB Receptors | 31 | 2006 | 485 | 1.930 |
Why?
|
Signal Transduction | 36 | 2022 | 3233 | 1.900 |
Why?
|
Neoplasm Metastasis | 15 | 2023 | 1056 | 1.880 |
Why?
|
Triple Negative Breast Neoplasms | 5 | 2019 | 136 | 1.690 |
Why?
|
Protein Kinase C | 22 | 2022 | 270 | 1.570 |
Why?
|
Epidermal Growth Factor | 22 | 2010 | 119 | 1.530 |
Why?
|
Proto-Oncogene Proteins c-raf | 13 | 2014 | 47 | 1.410 |
Why?
|
Animals | 138 | 2022 | 26518 | 1.350 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 14 | 1999 | 85 | 1.300 |
Why?
|
Phosphorylation | 37 | 2022 | 1101 | 1.280 |
Why?
|
Breast Neoplasms | 14 | 2023 | 2881 | 1.240 |
Why?
|
Neurons | 21 | 2005 | 1545 | 1.230 |
Why?
|
MAP Kinase Signaling System | 15 | 2021 | 192 | 1.220 |
Why?
|
MicroRNAs | 6 | 2013 | 534 | 1.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2016 | 1196 | 1.150 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 4 | 2023 | 41 | 1.150 |
Why?
|
Rats | 56 | 2011 | 3984 | 1.150 |
Why?
|
Cell Nucleus | 9 | 2011 | 579 | 1.130 |
Why?
|
Cell Line | 49 | 2011 | 2466 | 1.090 |
Why?
|
Tuberous Sclerosis | 6 | 2009 | 28 | 1.090 |
Why?
|
HMGA2 Protein | 3 | 2015 | 14 | 1.070 |
Why?
|
Cytoplasm | 6 | 2011 | 281 | 1.030 |
Why?
|
Protein Kinases | 9 | 2021 | 209 | 1.020 |
Why?
|
Mice | 57 | 2022 | 11313 | 1.010 |
Why?
|
Cell Line, Tumor | 22 | 2021 | 2421 | 0.990 |
Why?
|
Enzyme Activation | 26 | 2013 | 692 | 0.930 |
Why?
|
Proto-Oncogene Proteins | 9 | 2013 | 645 | 0.910 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 6 | 2007 | 115 | 0.890 |
Why?
|
Sirolimus | 5 | 2011 | 169 | 0.870 |
Why?
|
Transfection | 25 | 2012 | 895 | 0.840 |
Why?
|
TOR Serine-Threonine Kinases | 10 | 2011 | 182 | 0.840 |
Why?
|
Insulin | 13 | 2008 | 1159 | 0.840 |
Why?
|
Cells, Cultured | 38 | 2013 | 2810 | 0.830 |
Why?
|
Hippocampus | 15 | 2005 | 442 | 0.830 |
Why?
|
Chemotaxis | 2 | 2015 | 72 | 0.830 |
Why?
|
Guanine Nucleotide Exchange Factors | 4 | 2012 | 73 | 0.820 |
Why?
|
rap1 GTP-Binding Proteins | 2 | 2012 | 13 | 0.810 |
Why?
|
Neovascularization, Pathologic | 5 | 2013 | 352 | 0.780 |
Why?
|
Humans | 119 | 2023 | 86281 | 0.780 |
Why?
|
Gene Regulatory Networks | 3 | 2014 | 291 | 0.780 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 4 | 2022 | 106 | 0.740 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2014 | 427 | 0.740 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2009 | 378 | 0.710 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 8 | 2012 | 36 | 0.700 |
Why?
|
Hemin | 1 | 2019 | 5 | 0.700 |
Why?
|
Genes, Tumor Suppressor | 3 | 2014 | 157 | 0.690 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 5 | 2011 | 44 | 0.670 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2013 | 137 | 0.660 |
Why?
|
Mice, Nude | 9 | 2021 | 790 | 0.650 |
Why?
|
Apoptosis | 13 | 2012 | 1678 | 0.650 |
Why?
|
Cell Cycle | 9 | 2010 | 502 | 0.640 |
Why?
|
Growth Substances | 8 | 2005 | 80 | 0.630 |
Why?
|
raf Kinases | 6 | 2010 | 12 | 0.610 |
Why?
|
Models, Biological | 9 | 2015 | 1748 | 0.610 |
Why?
|
Metformin | 1 | 2019 | 128 | 0.600 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2015 | 124 | 0.600 |
Why?
|
Macrophages | 4 | 2019 | 554 | 0.600 |
Why?
|
Cell Proliferation | 11 | 2013 | 1571 | 0.600 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2017 | 72 | 0.590 |
Why?
|
HeLa Cells | 12 | 2012 | 498 | 0.580 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 532 | 0.570 |
Why?
|
Isoenzymes | 5 | 2008 | 271 | 0.570 |
Why?
|
Adenylyl Cyclases | 2 | 2007 | 100 | 0.560 |
Why?
|
Cyclic AMP | 3 | 2012 | 273 | 0.550 |
Why?
|
Stromal Cells | 1 | 2016 | 142 | 0.550 |
Why?
|
Mitosis | 3 | 2010 | 151 | 0.550 |
Why?
|
Molecular Sequence Data | 21 | 2006 | 3029 | 0.530 |
Why?
|
Mitochondria | 1 | 2019 | 535 | 0.530 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 8 | 2012 | 101 | 0.530 |
Why?
|
Chemokines | 1 | 2015 | 72 | 0.530 |
Why?
|
Androgen-Binding Protein | 2 | 2006 | 7 | 0.520 |
Why?
|
Carcinogens | 8 | 1999 | 108 | 0.520 |
Why?
|
DNA-Binding Proteins | 5 | 2013 | 1208 | 0.510 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 275 | 0.500 |
Why?
|
Amino Acid Sequence | 19 | 2009 | 2062 | 0.500 |
Why?
|
Myocardium | 1 | 2017 | 528 | 0.490 |
Why?
|
Syndecan-2 | 1 | 2013 | 1 | 0.480 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2013 | 4 | 0.480 |
Why?
|
Ribosomal Protein S6 | 2 | 2010 | 4 | 0.480 |
Why?
|
Fibroblasts | 13 | 2011 | 729 | 0.480 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2011 | 1075 | 0.470 |
Why?
|
Phorbol 12,13-Dibutyrate | 11 | 1999 | 20 | 0.450 |
Why?
|
Fibroblast Growth Factor 2 | 5 | 2003 | 57 | 0.440 |
Why?
|
Protein Binding | 13 | 2017 | 1454 | 0.440 |
Why?
|
Head and Neck Neoplasms | 4 | 2011 | 1051 | 0.440 |
Why?
|
Base Sequence | 16 | 2010 | 2329 | 0.440 |
Why?
|
Gene Expression Regulation | 9 | 2011 | 1917 | 0.430 |
Why?
|
Protein-Tyrosine Kinases | 10 | 2001 | 302 | 0.420 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 415 | 0.420 |
Why?
|
Recombinant Fusion Proteins | 10 | 2008 | 555 | 0.420 |
Why?
|
Repressor Proteins | 5 | 2004 | 403 | 0.420 |
Why?
|
MAP Kinase Kinase 5 | 2 | 2009 | 11 | 0.410 |
Why?
|
Proteins | 7 | 2010 | 777 | 0.410 |
Why?
|
Fibroblast Growth Factors | 5 | 1999 | 80 | 0.410 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 2 | 2009 | 21 | 0.410 |
Why?
|
Transcription, Genetic | 13 | 2014 | 1135 | 0.410 |
Why?
|
Carrier Proteins | 5 | 2009 | 672 | 0.400 |
Why?
|
Homeodomain Proteins | 2 | 2013 | 535 | 0.400 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2009 | 43 | 0.400 |
Why?
|
RNA, Messenger | 16 | 2022 | 1975 | 0.400 |
Why?
|
Neoplasms | 8 | 2021 | 2889 | 0.390 |
Why?
|
Oncogene Protein v-akt | 3 | 2006 | 21 | 0.370 |
Why?
|
Transcriptome | 2 | 2013 | 574 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2010 | 321 | 0.360 |
Why?
|
Prognosis | 6 | 2016 | 3669 | 0.360 |
Why?
|
Thrombospondins | 1 | 2009 | 14 | 0.360 |
Why?
|
Nerve Tissue Proteins | 4 | 2009 | 503 | 0.360 |
Why?
|
Drosophila melanogaster | 7 | 2001 | 596 | 0.360 |
Why?
|
Oxazolidinones | 1 | 2009 | 11 | 0.360 |
Why?
|
Fluorescent Antibody Technique | 2 | 2010 | 314 | 0.360 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 8 | 2013 | 74 | 0.350 |
Why?
|
Blotting, Western | 8 | 2012 | 781 | 0.350 |
Why?
|
Acrylamides | 4 | 1989 | 30 | 0.340 |
Why?
|
Cnidarian Venoms | 4 | 1989 | 19 | 0.340 |
Why?
|
Protein Kinase C-alpha | 1 | 2009 | 27 | 0.340 |
Why?
|
Nuclear Proteins | 3 | 2007 | 694 | 0.340 |
Why?
|
Allosteric Regulation | 1 | 2008 | 68 | 0.340 |
Why?
|
Protein Kinase Inhibitors | 6 | 2021 | 589 | 0.330 |
Why?
|
Cloning, Molecular | 7 | 2002 | 646 | 0.330 |
Why?
|
Mutagenesis, Site-Directed | 7 | 2001 | 279 | 0.330 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 179 | 0.330 |
Why?
|
Substrate Specificity | 12 | 2012 | 347 | 0.320 |
Why?
|
Transcription Factors | 8 | 2022 | 1555 | 0.320 |
Why?
|
Promoter Regions, Genetic | 8 | 2014 | 937 | 0.320 |
Why?
|
Kinetics | 17 | 1998 | 1513 | 0.320 |
Why?
|
Endothelial Cells | 2 | 2009 | 427 | 0.320 |
Why?
|
Carcinoma | 1 | 2011 | 434 | 0.320 |
Why?
|
Cell Division | 10 | 2008 | 696 | 0.310 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 2 | 1997 | 12 | 0.310 |
Why?
|
Telomere-Binding Proteins | 1 | 2007 | 14 | 0.310 |
Why?
|
Trachea | 6 | 2002 | 293 | 0.310 |
Why?
|
Muscle, Smooth | 6 | 2002 | 354 | 0.300 |
Why?
|
Conserved Sequence | 4 | 2017 | 210 | 0.300 |
Why?
|
Heterografts | 2 | 2019 | 98 | 0.300 |
Why?
|
RNA Interference | 3 | 2013 | 368 | 0.300 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 3087 | 0.290 |
Why?
|
Thapsigargin | 6 | 1997 | 55 | 0.290 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 244 | 0.290 |
Why?
|
Down-Regulation | 9 | 2013 | 504 | 0.290 |
Why?
|
bcl-Associated Death Protein | 1 | 2006 | 16 | 0.290 |
Why?
|
Retina | 3 | 1993 | 212 | 0.290 |
Why?
|
Female | 24 | 2023 | 44405 | 0.280 |
Why?
|
Gene Expression Profiling | 5 | 2015 | 1381 | 0.280 |
Why?
|
Spindle Apparatus | 1 | 2006 | 64 | 0.280 |
Why?
|
RNA, Neoplasm | 2 | 2016 | 87 | 0.280 |
Why?
|
Serine | 4 | 2017 | 99 | 0.280 |
Why?
|
Enzyme Inhibitors | 8 | 2003 | 632 | 0.280 |
Why?
|
Cysteine Endopeptidases | 2 | 2004 | 87 | 0.280 |
Why?
|
Cyclin D1 | 7 | 2011 | 83 | 0.280 |
Why?
|
Cell Fusion | 1 | 2005 | 39 | 0.270 |
Why?
|
Rett Syndrome | 1 | 2005 | 19 | 0.270 |
Why?
|
14-3-3 Proteins | 1 | 2005 | 10 | 0.270 |
Why?
|
Spasms, Infantile | 1 | 2005 | 30 | 0.270 |
Why?
|
Cell Differentiation | 12 | 2005 | 1456 | 0.270 |
Why?
|
Structure-Activity Relationship | 5 | 2014 | 408 | 0.270 |
Why?
|
Mutation | 14 | 2016 | 3952 | 0.270 |
Why?
|
Cell Survival | 9 | 2011 | 966 | 0.270 |
Why?
|
Prostatic Neoplasms | 3 | 2022 | 1708 | 0.260 |
Why?
|
DNA | 10 | 2005 | 1293 | 0.260 |
Why?
|
Transplantation, Heterologous | 3 | 2016 | 363 | 0.260 |
Why?
|
Cattle | 10 | 2005 | 374 | 0.260 |
Why?
|
Cell Cycle Proteins | 4 | 2012 | 388 | 0.260 |
Why?
|
Sequence Homology, Amino Acid | 6 | 2002 | 416 | 0.260 |
Why?
|
Biological Evolution | 5 | 2015 | 917 | 0.250 |
Why?
|
Gene Expression | 8 | 2013 | 1281 | 0.250 |
Why?
|
Peptide Hydrolases | 3 | 1989 | 100 | 0.250 |
Why?
|
Sequence Analysis, RNA | 2 | 2016 | 217 | 0.250 |
Why?
|
Immunohistochemistry | 9 | 2012 | 1752 | 0.250 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 2 | 2014 | 8 | 0.240 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 64 | 0.240 |
Why?
|
Cell Line, Transformed | 7 | 2003 | 153 | 0.240 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 977 | 0.240 |
Why?
|
NF-kappa B | 5 | 2009 | 442 | 0.240 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2013 | 689 | 0.240 |
Why?
|
Zinc | 2 | 1994 | 91 | 0.240 |
Why?
|
Immunity, Innate | 2 | 2022 | 405 | 0.230 |
Why?
|
Ubiquitin | 1 | 2004 | 93 | 0.230 |
Why?
|
Transforming Growth Factor alpha | 3 | 1997 | 50 | 0.230 |
Why?
|
RNA, Small Interfering | 6 | 2013 | 547 | 0.230 |
Why?
|
RNA, Transfer | 3 | 2016 | 151 | 0.230 |
Why?
|
Threonine | 3 | 1993 | 33 | 0.230 |
Why?
|
Phenotype | 5 | 2019 | 2375 | 0.230 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2010 | 1958 | 0.220 |
Why?
|
Middle East Respiratory Syndrome Coronavirus | 1 | 2022 | 9 | 0.220 |
Why?
|
COS Cells | 5 | 2002 | 166 | 0.220 |
Why?
|
DNA, Neoplasm | 4 | 2009 | 265 | 0.220 |
Why?
|
Tissue Distribution | 4 | 2011 | 290 | 0.220 |
Why?
|
Protein Biosynthesis | 5 | 2013 | 378 | 0.220 |
Why?
|
Methylprednisolone | 2 | 1992 | 66 | 0.220 |
Why?
|
Protein Isoforms | 3 | 2011 | 269 | 0.220 |
Why?
|
ras Proteins | 2 | 2007 | 128 | 0.220 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 53 | 0.220 |
Why?
|
Radiation Injuries, Experimental | 2 | 1992 | 41 | 0.220 |
Why?
|
Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
Butadienes | 4 | 2016 | 33 | 0.210 |
Why?
|
Genes, Immediate-Early | 2 | 1999 | 17 | 0.210 |
Why?
|
MAP Kinase Kinase 2 | 3 | 2016 | 14 | 0.210 |
Why?
|
Disease-Free Survival | 2 | 2015 | 1203 | 0.210 |
Why?
|
Clone Cells | 4 | 2015 | 213 | 0.200 |
Why?
|
Nitriles | 4 | 2016 | 145 | 0.200 |
Why?
|
Cricetinae | 8 | 2009 | 560 | 0.200 |
Why?
|
Imatinib Mesylate | 1 | 2021 | 126 | 0.200 |
Why?
|
Light | 2 | 1992 | 289 | 0.200 |
Why?
|
Immunoblotting | 2 | 2013 | 267 | 0.200 |
Why?
|
Protein Structure, Tertiary | 6 | 2006 | 736 | 0.200 |
Why?
|
Neoplasm Invasiveness | 2 | 2013 | 551 | 0.200 |
Why?
|
Protein Conformation | 4 | 2014 | 881 | 0.200 |
Why?
|
Amniotic Fluid | 2 | 2011 | 30 | 0.200 |
Why?
|
Bacterial Proteins | 1 | 2007 | 861 | 0.200 |
Why?
|
Calcium | 4 | 1994 | 1148 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2015 | 589 | 0.190 |
Why?
|
Receptors, Cell Surface | 4 | 1989 | 286 | 0.190 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 877 | 0.190 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 78 | 0.190 |
Why?
|
Cyclins | 2 | 1997 | 82 | 0.190 |
Why?
|
Cyclin E | 2 | 2012 | 27 | 0.190 |
Why?
|
Tumor Cells, Cultured | 9 | 2011 | 1040 | 0.190 |
Why?
|
Microbodies | 2 | 1997 | 7 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2013 | 68 | 0.190 |
Why?
|
Blotting, Northern | 5 | 2002 | 256 | 0.190 |
Why?
|
Leucine | 2 | 1997 | 67 | 0.190 |
Why?
|
DNA Primers | 4 | 2010 | 542 | 0.180 |
Why?
|
Terpenes | 3 | 1996 | 17 | 0.180 |
Why?
|
Host-Pathogen Interactions | 1 | 2022 | 230 | 0.180 |
Why?
|
Transforming Growth Factors | 2 | 1989 | 12 | 0.180 |
Why?
|
Protein Kinase C-delta | 4 | 2006 | 26 | 0.180 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2005 | 211 | 0.180 |
Why?
|
Proline | 1 | 1999 | 57 | 0.180 |
Why?
|
Mice, Knockout | 3 | 2013 | 1918 | 0.170 |
Why?
|
Citric Acid Cycle | 1 | 2019 | 21 | 0.170 |
Why?
|
Tyrosine | 6 | 2005 | 133 | 0.170 |
Why?
|
Electron Transport | 1 | 2019 | 71 | 0.170 |
Why?
|
Alkaloids | 3 | 2006 | 45 | 0.170 |
Why?
|
Glutamine | 1 | 1999 | 76 | 0.170 |
Why?
|
Binding Sites | 5 | 2010 | 1098 | 0.170 |
Why?
|
Indoles | 2 | 2011 | 318 | 0.170 |
Why?
|
Escherichia coli | 2 | 2000 | 596 | 0.170 |
Why?
|
Chloride Channels | 1 | 1999 | 42 | 0.170 |
Why?
|
Receptor, Insulin | 3 | 1990 | 54 | 0.170 |
Why?
|
NIH 3T3 Cells | 3 | 2010 | 105 | 0.170 |
Why?
|
Proteolysis | 1 | 2019 | 100 | 0.170 |
Why?
|
Aging | 2 | 1993 | 689 | 0.170 |
Why?
|
PC12 Cells | 5 | 2002 | 115 | 0.160 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2001 | 276 | 0.160 |
Why?
|
Stem Cells | 2 | 2011 | 350 | 0.160 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2007 | 114 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2007 | 262 | 0.160 |
Why?
|
Molecular Weight | 8 | 1996 | 332 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2006 | 189 | 0.160 |
Why?
|
Antiviral Agents | 1 | 2022 | 508 | 0.160 |
Why?
|
Recombinant Proteins | 5 | 2001 | 1014 | 0.160 |
Why?
|
Sodium | 2 | 1989 | 340 | 0.160 |
Why?
|
Cell Growth Processes | 2 | 2009 | 83 | 0.160 |
Why?
|
Protein Interaction Maps | 1 | 2017 | 48 | 0.160 |
Why?
|
Obesity | 2 | 2019 | 962 | 0.160 |
Why?
|
Retroviridae Proteins, Oncogenic | 2 | 1998 | 9 | 0.150 |
Why?
|
Mouth Mucosa | 2 | 2009 | 66 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 458 | 0.150 |
Why?
|
Drosophila Proteins | 3 | 2001 | 486 | 0.150 |
Why?
|
Protein Transport | 3 | 2010 | 410 | 0.150 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1998 | 153 | 0.150 |
Why?
|
Epithelial Cells | 3 | 2022 | 662 | 0.150 |
Why?
|
Cytoskeleton | 2 | 2009 | 192 | 0.150 |
Why?
|
Adipose Tissue | 1 | 2019 | 240 | 0.150 |
Why?
|
Plant Extracts | 2 | 1989 | 243 | 0.150 |
Why?
|
DNA, Complementary | 4 | 2002 | 393 | 0.140 |
Why?
|
Metalloendopeptidases | 3 | 1991 | 45 | 0.140 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 1996 | 10 | 0.140 |
Why?
|
Biomarkers, Tumor | 3 | 2014 | 1461 | 0.140 |
Why?
|
Oxidative Stress | 3 | 2014 | 446 | 0.140 |
Why?
|
MAP Kinase Kinase Kinases | 3 | 2007 | 41 | 0.140 |
Why?
|
Amyloid beta-Peptides | 4 | 2006 | 203 | 0.140 |
Why?
|
Cadherins | 1 | 2016 | 151 | 0.140 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 1047 | 0.140 |
Why?
|
Glucose | 1 | 2019 | 637 | 0.140 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 3 | 2010 | 29 | 0.140 |
Why?
|
Plasmids | 4 | 2012 | 287 | 0.140 |
Why?
|
Cyclohexanes | 1 | 2015 | 9 | 0.140 |
Why?
|
Antigens, Bacterial | 2 | 2007 | 134 | 0.140 |
Why?
|
Bacterial Toxins | 2 | 2007 | 111 | 0.140 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 17 | 0.140 |
Why?
|
Chemokine CCL5 | 1 | 2015 | 16 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 5 | 2005 | 1214 | 0.140 |
Why?
|
Histamine | 1 | 1995 | 126 | 0.130 |
Why?
|
Mitogens | 2 | 2002 | 64 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2017 | 371 | 0.130 |
Why?
|
Stochastic Processes | 1 | 2015 | 74 | 0.130 |
Why?
|
Multiprotein Complexes | 3 | 2010 | 94 | 0.130 |
Why?
|
Male | 13 | 2022 | 40860 | 0.130 |
Why?
|
Precipitin Tests | 3 | 2002 | 108 | 0.130 |
Why?
|
Triazoles | 1 | 2015 | 96 | 0.130 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 234 | 0.130 |
Why?
|
Dacryocystorhinostomy | 1 | 1994 | 4 | 0.130 |
Why?
|
Genes, Regulator | 1 | 1994 | 65 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2007 | 199 | 0.120 |
Why?
|
Conjunctiva | 1 | 1994 | 19 | 0.120 |
Why?
|
Glioma | 2 | 2012 | 285 | 0.120 |
Why?
|
Pyramidal Cells | 1 | 1994 | 80 | 0.120 |
Why?
|
Neurites | 3 | 1999 | 35 | 0.120 |
Why?
|
Heart | 1 | 2017 | 538 | 0.120 |
Why?
|
CHO Cells | 4 | 2009 | 187 | 0.120 |
Why?
|
Chromatography, Affinity | 3 | 2001 | 81 | 0.120 |
Why?
|
Amino Acid Motifs | 3 | 2014 | 116 | 0.120 |
Why?
|
Phorbol Esters | 4 | 1987 | 22 | 0.120 |
Why?
|
Endopeptidases | 2 | 1991 | 116 | 0.120 |
Why?
|
Organ Specificity | 4 | 2008 | 257 | 0.120 |
Why?
|
Wnt1 Protein | 1 | 2013 | 24 | 0.120 |
Why?
|
Prostheses and Implants | 1 | 1994 | 121 | 0.120 |
Why?
|
Phospholipids | 1 | 2014 | 111 | 0.120 |
Why?
|
Staining and Labeling | 2 | 2010 | 165 | 0.120 |
Why?
|
Antineoplastic Agents | 3 | 2014 | 2351 | 0.120 |
Why?
|
Chromatin | 2 | 2006 | 378 | 0.120 |
Why?
|
Platelet-Derived Growth Factor | 6 | 2002 | 67 | 0.120 |
Why?
|
Models, Molecular | 3 | 2014 | 1284 | 0.120 |
Why?
|
Animals, Newborn | 2 | 1995 | 509 | 0.120 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1993 | 46 | 0.120 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2013 | 18 | 0.110 |
Why?
|
RNA, Transfer, Amino Acyl | 1 | 2013 | 11 | 0.110 |
Why?
|
Mixed Function Oxygenases | 1 | 2013 | 68 | 0.110 |
Why?
|
RNA, Transfer, Ser | 1 | 2012 | 2 | 0.110 |
Why?
|
Ethers, Cyclic | 1 | 1992 | 7 | 0.110 |
Why?
|
Electrodes | 1 | 1993 | 78 | 0.110 |
Why?
|
Mice, Transgenic | 2 | 2013 | 1537 | 0.110 |
Why?
|
Electroretinography | 1 | 1993 | 76 | 0.110 |
Why?
|
Embryo, Mammalian | 3 | 2006 | 207 | 0.110 |
Why?
|
Survival Rate | 1 | 2016 | 1856 | 0.110 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1992 | 57 | 0.110 |
Why?
|
Rabbits | 3 | 2000 | 636 | 0.110 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2001 | 36 | 0.110 |
Why?
|
Methionine | 2 | 2009 | 66 | 0.110 |
Why?
|
Transforming Growth Factor beta | 1 | 1994 | 298 | 0.110 |
Why?
|
Thymidine | 3 | 2010 | 59 | 0.110 |
Why?
|
Disease Progression | 4 | 2014 | 1531 | 0.110 |
Why?
|
Testis | 2 | 2005 | 152 | 0.110 |
Why?
|
Methylmercury Compounds | 1 | 2011 | 3 | 0.110 |
Why?
|
Cell Movement | 2 | 2021 | 756 | 0.110 |
Why?
|
Drosophila | 4 | 1994 | 494 | 0.110 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2022 | 83 | 0.100 |
Why?
|
Neoplasm Transplantation | 2 | 2011 | 391 | 0.100 |
Why?
|
Interferons | 2 | 2022 | 132 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 376 | 0.100 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 272 | 0.100 |
Why?
|
Chromatography, Gel | 6 | 2000 | 103 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2011 | 96 | 0.100 |
Why?
|
Endoribonucleases | 2 | 2022 | 92 | 0.100 |
Why?
|
Molecular Biology | 1 | 2011 | 89 | 0.100 |
Why?
|
G1 Phase | 1 | 2011 | 63 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 318 | 0.100 |
Why?
|
Toxins, Biological | 1 | 1990 | 7 | 0.100 |
Why?
|
Time Factors | 8 | 2015 | 5198 | 0.100 |
Why?
|
Proto-Oncogenes | 2 | 1989 | 61 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2004 | 351 | 0.100 |
Why?
|
Organometallic Compounds | 1 | 2011 | 132 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 859 | 0.100 |
Why?
|
Patient Satisfaction | 1 | 1994 | 452 | 0.100 |
Why?
|
Models, Theoretical | 2 | 2014 | 480 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 407 | 0.100 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2002 | 348 | 0.100 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 645 | 0.100 |
Why?
|
Analysis of Variance | 1 | 2012 | 912 | 0.090 |
Why?
|
fas Receptor | 2 | 2001 | 75 | 0.090 |
Why?
|
Sarcoma Virus, Woolly Monkey | 1 | 1989 | 1 | 0.090 |
Why?
|
Retroviruses, Simian | 1 | 1989 | 1 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 274 | 0.090 |
Why?
|
Transfer RNA Aminoacylation | 1 | 2009 | 18 | 0.090 |
Why?
|
Oligonucleotides, Antisense | 2 | 2000 | 69 | 0.090 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2009 | 8 | 0.090 |
Why?
|
Homeostasis | 1 | 2012 | 408 | 0.090 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 826 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2010 | 61 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2005 | 622 | 0.090 |
Why?
|
Survival Analysis | 1 | 2013 | 1536 | 0.090 |
Why?
|
Intermediate Filament Proteins | 1 | 2009 | 35 | 0.090 |
Why?
|
Vimentin | 1 | 2009 | 44 | 0.090 |
Why?
|
Liver | 3 | 1993 | 1229 | 0.090 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2007 | 75 | 0.090 |
Why?
|
Glycoproteins | 4 | 1986 | 234 | 0.090 |
Why?
|
G-Protein-Coupled Receptor Kinase 2 | 1 | 2009 | 22 | 0.090 |
Why?
|
RNA | 3 | 2005 | 560 | 0.080 |
Why?
|
Diglycerides | 2 | 1987 | 22 | 0.080 |
Why?
|
Breast | 2 | 2009 | 286 | 0.080 |
Why?
|
Viral Proteins | 4 | 1986 | 300 | 0.080 |
Why?
|
Muscles | 1 | 1989 | 192 | 0.080 |
Why?
|
Rats, Inbred Lew | 3 | 1993 | 186 | 0.080 |
Why?
|
Receptors, Estrogen | 3 | 2007 | 382 | 0.080 |
Why?
|
Tretinoin | 1 | 1989 | 125 | 0.080 |
Why?
|
Feedback, Physiological | 2 | 2022 | 62 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2002 | 683 | 0.080 |
Why?
|
Fibronectins | 1 | 1988 | 93 | 0.080 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2008 | 23 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2006 | 113 | 0.080 |
Why?
|
Genomic Instability | 1 | 2008 | 79 | 0.080 |
Why?
|
3T3 Cells | 4 | 1996 | 94 | 0.080 |
Why?
|
Protease Inhibitors | 3 | 1996 | 72 | 0.080 |
Why?
|
Tubulin | 1 | 2008 | 58 | 0.080 |
Why?
|
Genes | 1 | 1988 | 305 | 0.080 |
Why?
|
Gene Library | 2 | 2002 | 130 | 0.080 |
Why?
|
Kidney | 5 | 1999 | 1240 | 0.080 |
Why?
|
Simian virus 40 | 3 | 2003 | 35 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 114 | 0.080 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1993 | 173 | 0.080 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 927 | 0.080 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 2007 | 8 | 0.080 |
Why?
|
Catalysis | 2 | 2001 | 203 | 0.080 |
Why?
|
Receptors, Peptide | 1 | 2007 | 16 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 1305 | 0.080 |
Why?
|
Reproducibility of Results | 1 | 2013 | 2699 | 0.080 |
Why?
|
DNA, Recombinant | 1 | 1986 | 67 | 0.070 |
Why?
|
Temperature | 4 | 2003 | 395 | 0.070 |
Why?
|
Cohort Studies | 1 | 2013 | 2759 | 0.070 |
Why?
|
Alanine | 2 | 1997 | 85 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2013 | 7949 | 0.070 |
Why?
|
Antigens, Polyomavirus Transforming | 3 | 1996 | 47 | 0.070 |
Why?
|
Secretoglobins | 1 | 2006 | 1 | 0.070 |
Why?
|
Prostatein | 1 | 2006 | 1 | 0.070 |
Why?
|
Uteroglobin | 1 | 2006 | 4 | 0.070 |
Why?
|
Estradiol | 2 | 1999 | 249 | 0.070 |
Why?
|
Nocodazole | 1 | 2006 | 18 | 0.070 |
Why?
|
Kinetochores | 1 | 2006 | 7 | 0.070 |
Why?
|
Aurora Kinases | 1 | 2006 | 17 | 0.070 |
Why?
|
Metaphase | 1 | 2006 | 25 | 0.070 |
Why?
|
Aurora Kinase B | 1 | 2006 | 14 | 0.070 |
Why?
|
Centrosome | 1 | 2006 | 22 | 0.070 |
Why?
|
Moloney murine leukemia virus | 1 | 1986 | 5 | 0.070 |
Why?
|
BRCA2 Protein | 1 | 2007 | 157 | 0.070 |
Why?
|
Benzophenanthridines | 1 | 2006 | 23 | 0.070 |
Why?
|
Phenanthridines | 1 | 2006 | 24 | 0.070 |
Why?
|
Phosphotransferases | 1 | 2006 | 65 | 0.070 |
Why?
|
DNA Fragmentation | 1 | 2006 | 63 | 0.070 |
Why?
|
Ligands | 3 | 2010 | 433 | 0.070 |
Why?
|
Receptors, Virus | 1 | 1986 | 74 | 0.070 |
Why?
|
Hyperglycemia | 1 | 1987 | 176 | 0.070 |
Why?
|
BRCA1 Protein | 1 | 2007 | 199 | 0.070 |
Why?
|
Binding, Competitive | 3 | 1993 | 145 | 0.070 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2005 | 16 | 0.070 |
Why?
|
Nucleic Acid Hybridization | 4 | 1991 | 245 | 0.070 |
Why?
|
Electrophysiology | 2 | 1999 | 401 | 0.070 |
Why?
|
Brain Neoplasms | 1 | 2012 | 763 | 0.070 |
Why?
|
Fas Ligand Protein | 2 | 2006 | 49 | 0.070 |
Why?
|
Neoplastic Stem Cells | 2 | 2019 | 143 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 2 | 2011 | 121 | 0.070 |
Why?
|
Brain | 4 | 2005 | 2211 | 0.070 |
Why?
|
Asparagine | 2 | 1983 | 29 | 0.070 |
Why?
|
Cell Shape | 1 | 2005 | 50 | 0.070 |
Why?
|
Cross Reactions | 2 | 2001 | 106 | 0.070 |
Why?
|
Keratinocytes | 1 | 2006 | 143 | 0.070 |
Why?
|
Crystallography, X-Ray | 2 | 2006 | 484 | 0.070 |
Why?
|
Receptor, IGF Type 1 | 2 | 2007 | 44 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 2 | 2000 | 176 | 0.070 |
Why?
|
Aspartic Acid | 1 | 2005 | 64 | 0.070 |
Why?
|
Catalytic Domain | 1 | 2005 | 156 | 0.070 |
Why?
|
Transcriptional Activation | 2 | 1998 | 280 | 0.070 |
Why?
|
DNA Replication | 4 | 1995 | 164 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2005 | 134 | 0.070 |
Why?
|
Up-Regulation | 1 | 2007 | 710 | 0.060 |
Why?
|
Glycerides | 1 | 1984 | 17 | 0.060 |
Why?
|
Chromosome Mapping | 3 | 2001 | 1074 | 0.060 |
Why?
|
Phorbols | 1 | 1984 | 9 | 0.060 |
Why?
|
Paclitaxel | 1 | 2006 | 460 | 0.060 |
Why?
|
Cysteine | 2 | 1996 | 131 | 0.060 |
Why?
|
Mouth Neoplasms | 1 | 2006 | 194 | 0.060 |
Why?
|
Serotonin | 2 | 1995 | 218 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2004 | 99 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2009 | 302 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 1994 | 502 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2000 | 268 | 0.060 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2003 | 5 | 0.060 |
Why?
|
Membrane Glycoproteins | 2 | 2006 | 428 | 0.060 |
Why?
|
Hydrolysis | 3 | 2006 | 141 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2003 | 132 | 0.060 |
Why?
|
X-Box Binding Protein 1 | 1 | 2022 | 17 | 0.060 |
Why?
|
Inositol | 1 | 2022 | 15 | 0.060 |
Why?
|
Iodine Radioisotopes | 2 | 1997 | 134 | 0.060 |
Why?
|
Cystatin M | 1 | 2002 | 2 | 0.060 |
Why?
|
Bronchi | 1 | 2003 | 229 | 0.060 |
Why?
|
Cystatins | 1 | 2002 | 5 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 2 | 2000 | 36 | 0.050 |
Why?
|
Cathepsins | 1 | 2002 | 21 | 0.050 |
Why?
|
Ribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
Polyisoprenyl Phosphate Oligosaccharides | 1 | 1982 | 1 | 0.050 |
Why?
|
Polyisoprenyl Phosphate Sugars | 1 | 1982 | 1 | 0.050 |
Why?
|
A549 Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 100 | 0.050 |
Why?
|
Glycosylation | 1 | 2002 | 129 | 0.050 |
Why?
|
Cell Membrane | 1 | 2005 | 664 | 0.050 |
Why?
|
src-Family Kinases | 1 | 2002 | 74 | 0.050 |
Why?
|
Androstadienes | 2 | 1999 | 72 | 0.050 |
Why?
|
Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
Antigens, Viral, Tumor | 2 | 2003 | 15 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2002 | 111 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2002 | 85 | 0.050 |
Why?
|
Cell Compartmentation | 2 | 2001 | 69 | 0.050 |
Why?
|
Tissue Extracts | 2 | 2008 | 24 | 0.050 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2001 | 13 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 20 | 0.050 |
Why?
|
Caspase Inhibitors | 1 | 2001 | 33 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2022 | 89 | 0.050 |
Why?
|
Egtazic Acid | 2 | 1992 | 34 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 43 | 0.050 |
Why?
|
Peptide Fragments | 3 | 1989 | 460 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 88 | 0.050 |
Why?
|
Nerve Growth Factors | 2 | 1999 | 63 | 0.050 |
Why?
|
Caspases | 1 | 2001 | 155 | 0.050 |
Why?
|
Rauscher Virus | 1 | 1980 | 8 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2001 | 129 | 0.050 |
Why?
|
Introns | 1 | 2002 | 289 | 0.050 |
Why?
|
3-Phosphoinositide-Dependent Protein Kinases | 1 | 2000 | 5 | 0.050 |
Why?
|
Mutagenesis | 1 | 2001 | 199 | 0.050 |
Why?
|
Protein Kinase C-theta | 1 | 2000 | 16 | 0.050 |
Why?
|
Drug Combinations | 1 | 2021 | 222 | 0.050 |
Why?
|
Amino Acids | 3 | 1988 | 252 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2001 | 132 | 0.050 |
Why?
|
X Chromosome | 1 | 2001 | 152 | 0.050 |
Why?
|
Culture Media, Serum-Free | 2 | 1998 | 20 | 0.050 |
Why?
|
Virus Replication | 1 | 2022 | 319 | 0.050 |
Why?
|
Antigens, Viral | 1 | 1980 | 143 | 0.050 |
Why?
|
Nucleotides | 2 | 2011 | 95 | 0.050 |
Why?
|
Histidine | 1 | 2000 | 55 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2017 | 339 | 0.050 |
Why?
|
Exons | 1 | 2002 | 450 | 0.050 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2000 | 49 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 1989 | 315 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2001 | 314 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2001 | 206 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2001 | 276 | 0.050 |
Why?
|
Septal Nuclei | 1 | 1999 | 9 | 0.050 |
Why?
|
Calcimycin | 2 | 1990 | 33 | 0.050 |
Why?
|
Codon, Initiator | 1 | 1999 | 21 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 2019 | 6 | 0.040 |
Why?
|
Benzopyrans | 1 | 1999 | 20 | 0.040 |
Why?
|
Antigens, CD | 1 | 2001 | 457 | 0.040 |
Why?
|
Acetophenones | 1 | 1999 | 27 | 0.040 |
Why?
|
Mammary Glands, Human | 1 | 2019 | 22 | 0.040 |
Why?
|
Oligosaccharides | 4 | 1983 | 24 | 0.040 |
Why?
|
Infant | 1 | 2005 | 3036 | 0.040 |
Why?
|
Cycloheximide | 1 | 1999 | 56 | 0.040 |
Why?
|
Subcellular Fractions | 1 | 1999 | 93 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 1999 | 146 | 0.040 |
Why?
|
Cell Transformation, Viral | 2 | 2003 | 40 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2019 | 78 | 0.040 |
Why?
|
Chick Embryo | 3 | 2012 | 229 | 0.040 |
Why?
|
Bombesin | 2 | 1989 | 6 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 493 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2000 | 438 | 0.040 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 1998 | 8 | 0.040 |
Why?
|
Troponin C | 1 | 2017 | 2 | 0.040 |
Why?
|
Serum Response Factor | 1 | 1998 | 44 | 0.040 |
Why?
|
Antisense Elements (Genetics) | 1 | 1997 | 9 | 0.040 |
Why?
|
Dactinomycin | 2 | 2006 | 35 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2017 | 47 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2019 | 255 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 1997 | 28 | 0.040 |
Why?
|
Oncogene Protein pp60(v-src) | 1 | 1997 | 3 | 0.040 |
Why?
|
Peptide Mapping | 2 | 1997 | 26 | 0.040 |
Why?
|
Microinjections | 1 | 1997 | 70 | 0.040 |
Why?
|
Vesicular Transport Proteins | 1 | 2017 | 63 | 0.040 |
Why?
|
Cell Size | 2 | 2011 | 65 | 0.040 |
Why?
|
Affinity Labels | 2 | 1988 | 10 | 0.040 |
Why?
|
Sequence Deletion | 1 | 1998 | 205 | 0.040 |
Why?
|
Weight Loss | 1 | 2019 | 229 | 0.040 |
Why?
|
Valine | 1 | 1997 | 69 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 148 | 0.040 |
Why?
|
Carcinogenesis | 1 | 2019 | 194 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1996 | 380 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 1997 | 59 | 0.040 |
Why?
|
Flavonoids | 1 | 1997 | 85 | 0.040 |
Why?
|
Caspase 1 | 1 | 1996 | 18 | 0.040 |
Why?
|
Membrane Proteins | 4 | 2000 | 1194 | 0.040 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 1996 | 25 | 0.040 |
Why?
|
Lysine | 1 | 2017 | 147 | 0.040 |
Why?
|
Blotting, Southern | 3 | 1997 | 129 | 0.040 |
Why?
|
Phylogeny | 1 | 2002 | 1136 | 0.040 |
Why?
|
Oncogene Proteins v-raf | 1 | 1996 | 2 | 0.040 |
Why?
|
Lung | 1 | 2022 | 1167 | 0.040 |
Why?
|
Rats, Inbred Strains | 2 | 1993 | 312 | 0.040 |
Why?
|
Gene Deletion | 1 | 1997 | 328 | 0.030 |
Why?
|
Genes, Wilms Tumor | 1 | 1995 | 6 | 0.030 |
Why?
|
In Vitro Techniques | 2 | 1988 | 987 | 0.030 |
Why?
|
Diet | 1 | 2019 | 442 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 853 | 0.030 |
Why?
|
Bronchoconstrictor Agents | 1 | 1995 | 12 | 0.030 |
Why?
|
Receptors, Serotonin | 1 | 1995 | 34 | 0.030 |
Why?
|
Adult | 6 | 2013 | 25577 | 0.030 |
Why?
|
Normal Distribution | 1 | 2015 | 37 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 1992 | 2227 | 0.030 |
Why?
|
Genetic Fitness | 1 | 2015 | 37 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 73 | 0.030 |
Why?
|
NADPH Oxidases | 2 | 2009 | 81 | 0.030 |
Why?
|
Cytosol | 2 | 2000 | 189 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1994 | 71 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1994 | 58 | 0.030 |
Why?
|
Nasolacrimal Duct | 1 | 1994 | 2 | 0.030 |
Why?
|
Aged | 4 | 2013 | 18353 | 0.030 |
Why?
|
Enzyme Induction | 2 | 2010 | 88 | 0.030 |
Why?
|
Glass | 1 | 1994 | 15 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1994 | 68 | 0.030 |
Why?
|
Immediate-Early Proteins | 1 | 1995 | 164 | 0.030 |
Why?
|
Staurosporine | 2 | 1993 | 33 | 0.030 |
Why?
|
Adenovirus E3 Proteins | 1 | 1993 | 2 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2016 | 615 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 1994 | 157 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 1993 | 41 | 0.030 |
Why?
|
Point Mutation | 1 | 1994 | 246 | 0.030 |
Why?
|
Haplorhini | 1 | 1993 | 81 | 0.030 |
Why?
|
MCF-7 Cells | 1 | 2014 | 106 | 0.030 |
Why?
|
Models, Chemical | 1 | 2014 | 178 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 133 | 0.030 |
Why?
|
Glucagon | 2 | 2006 | 111 | 0.030 |
Why?
|
Immunosorbent Techniques | 2 | 1990 | 13 | 0.030 |
Why?
|
Glutamates | 1 | 1993 | 89 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 1993 | 63 | 0.030 |
Why?
|
Sindbis Virus | 2 | 1983 | 4 | 0.030 |
Why?
|
Contact Lenses | 1 | 1993 | 7 | 0.030 |
Why?
|
Glutamic Acid | 1 | 1993 | 152 | 0.030 |
Why?
|
Needles | 1 | 1993 | 35 | 0.030 |
Why?
|
Ionomycin | 1 | 1992 | 21 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2015 | 315 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 1992 | 13 | 0.030 |
Why?
|
Okadaic Acid | 1 | 1992 | 9 | 0.030 |
Why?
|
Middle Aged | 4 | 2013 | 24957 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 1992 | 15 | 0.030 |
Why?
|
Cornea | 1 | 1993 | 69 | 0.030 |
Why?
|
Rhodopsin | 1 | 1992 | 19 | 0.030 |
Why?
|
Protein Phosphatase 1 | 1 | 1992 | 34 | 0.030 |
Why?
|
Retroviridae | 1 | 1992 | 78 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 1992 | 102 | 0.030 |
Why?
|
F-Box-WD Repeat-Containing Protein 7 | 1 | 2012 | 4 | 0.030 |
Why?
|
E2F Transcription Factors | 1 | 2012 | 19 | 0.030 |
Why?
|
Interphase | 1 | 2012 | 34 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1993 | 329 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2012 | 8 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 28 | 0.030 |
Why?
|
ROC Curve | 1 | 2014 | 752 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2012 | 25 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2015 | 434 | 0.030 |
Why?
|
Cyclin A | 1 | 2011 | 28 | 0.030 |
Why?
|
Nobel Prize | 1 | 2011 | 10 | 0.030 |
Why?
|
Cell Count | 1 | 1992 | 194 | 0.030 |
Why?
|
Synthetic Biology | 1 | 2011 | 15 | 0.030 |
Why?
|
Ammonium Chloride | 1 | 1991 | 22 | 0.030 |
Why?
|
Chloroquine | 1 | 1991 | 12 | 0.030 |
Why?
|
Antibodies | 2 | 2008 | 349 | 0.030 |
Why?
|
Neuroglia | 1 | 1992 | 104 | 0.030 |
Why?
|
Food Contamination | 1 | 2011 | 31 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 74 | 0.030 |
Why?
|
Child | 2 | 2012 | 6913 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2017 | 813 | 0.030 |
Why?
|
Cricetulus | 2 | 2009 | 126 | 0.030 |
Why?
|
India | 1 | 2011 | 120 | 0.030 |
Why?
|
Bacitracin | 1 | 1991 | 3 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2011 | 72 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1991 | 34 | 0.030 |
Why?
|
Canada | 1 | 2011 | 204 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2011 | 92 | 0.030 |
Why?
|
Trypsin | 2 | 1989 | 95 | 0.030 |
Why?
|
Environmental Pollutants | 1 | 2011 | 50 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 132 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2015 | 502 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1991 | 47 | 0.020 |
Why?
|
Lysosomes | 1 | 1991 | 104 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 165 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1992 | 916 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1993 | 371 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 111 | 0.020 |
Why?
|
Drug Synergism | 1 | 2011 | 303 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2002 | 266 | 0.020 |
Why?
|
History, 20th Century | 1 | 2011 | 312 | 0.020 |
Why?
|
Leukemia | 1 | 1992 | 318 | 0.020 |
Why?
|
Imidazoles | 1 | 2011 | 163 | 0.020 |
Why?
|
Adolescent | 2 | 2012 | 8968 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 1990 | 32 | 0.020 |
Why?
|
Biomarkers | 1 | 1996 | 1709 | 0.020 |
Why?
|
Biological Assay | 1 | 2010 | 78 | 0.020 |
Why?
|
RNA, Transfer, Met | 1 | 2009 | 6 | 0.020 |
Why?
|
Cell Aggregation | 1 | 2009 | 39 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1989 | 19 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 727 | 0.020 |
Why?
|
Virulence Factors, Bordetella | 1 | 1989 | 26 | 0.020 |
Why?
|
Pertussis Toxin | 1 | 1989 | 31 | 0.020 |
Why?
|
Genetic Code | 1 | 2009 | 25 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2009 | 37 | 0.020 |
Why?
|
Genes, Dominant | 2 | 2001 | 117 | 0.020 |
Why?
|
Culture Media | 1 | 1989 | 146 | 0.020 |
Why?
|
Orthomyxoviridae | 1 | 2009 | 37 | 0.020 |
Why?
|
Monensin | 1 | 1989 | 16 | 0.020 |
Why?
|
Nestin | 1 | 2009 | 18 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2009 | 16 | 0.020 |
Why?
|
Second Messenger Systems | 1 | 1989 | 41 | 0.020 |
Why?
|
Piperazines | 1 | 2011 | 272 | 0.020 |
Why?
|
Codon | 1 | 2009 | 124 | 0.020 |
Why?
|
Prostate | 1 | 1993 | 374 | 0.020 |
Why?
|
Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2009 | 1 | 0.020 |
Why?
|
Regulatory-Associated Protein of mTOR | 1 | 2009 | 11 | 0.020 |
Why?
|
Cesium | 1 | 1989 | 25 | 0.020 |
Why?
|
Phosphothreonine | 1 | 1988 | 3 | 0.020 |
Why?
|
DNA Probes | 1 | 1989 | 77 | 0.020 |
Why?
|
Half-Life | 1 | 1989 | 96 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 92 | 0.020 |
Why?
|
Optic Nerve Diseases | 1 | 1989 | 18 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2002 | 137 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 1989 | 83 | 0.020 |
Why?
|
Sodium Channels | 1 | 1989 | 129 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2008 | 78 | 0.020 |
Why?
|
Ultracentrifugation | 1 | 1988 | 42 | 0.020 |
Why?
|
Ecdysone | 1 | 1988 | 2 | 0.020 |
Why?
|
Endocytosis | 1 | 1989 | 177 | 0.020 |
Why?
|
Adenoviridae | 1 | 2009 | 345 | 0.020 |
Why?
|
Membrane Potentials | 1 | 1989 | 435 | 0.020 |
Why?
|
Epitopes | 1 | 2008 | 255 | 0.020 |
Why?
|
Bacteria | 1 | 2011 | 445 | 0.020 |
Why?
|
Genetic Carrier Screening | 1 | 2007 | 60 | 0.020 |
Why?
|
Hormones | 1 | 1988 | 140 | 0.020 |
Why?
|
Mice, Obese | 1 | 1987 | 44 | 0.020 |
Why?
|
Oncogenes | 2 | 2003 | 88 | 0.020 |
Why?
|
Wheat Germ Agglutinins | 1 | 1987 | 16 | 0.020 |
Why?
|
Electrolytes | 1 | 1987 | 52 | 0.020 |
Why?
|
Species Specificity | 1 | 1989 | 678 | 0.020 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1987 | 20 | 0.020 |
Why?
|
Potassium | 1 | 1989 | 281 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 1989 | 247 | 0.020 |
Why?
|
Cell Extracts | 1 | 1987 | 15 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 1987 | 21 | 0.020 |
Why?
|
Laser Therapy | 1 | 1989 | 142 | 0.020 |
Why?
|
Dimethyl Sulfoxide | 1 | 1987 | 38 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 480 | 0.020 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2006 | 25 | 0.020 |
Why?
|
Genetic Variation | 1 | 2014 | 1349 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1991 | 380 | 0.020 |
Why?
|
Menopause | 1 | 2007 | 71 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 1993 | 1195 | 0.020 |
Why?
|
Blood Platelets | 1 | 1987 | 149 | 0.020 |
Why?
|
Amyloid | 1 | 2006 | 85 | 0.020 |
Why?
|
Tumor Necrosis Factors | 1 | 2006 | 14 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1992 | 1200 | 0.020 |
Why?
|
Phosphatidylethanolamines | 1 | 2006 | 15 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2006 | 49 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 1989 | 336 | 0.020 |
Why?
|
Immunologic Techniques | 1 | 1985 | 27 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2007 | 165 | 0.020 |
Why?
|
Dimerization | 1 | 2006 | 143 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 60 | 0.020 |
Why?
|
Solubility | 1 | 1986 | 177 | 0.020 |
Why?
|
Reference Values | 1 | 2007 | 673 | 0.020 |
Why?
|
Alzheimer Disease | 2 | 2000 | 470 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 1989 | 388 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 193 | 0.020 |
Why?
|
Phosphopeptides | 1 | 1984 | 11 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 3608 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 1991 | 731 | 0.020 |
Why?
|
Models, Genetic | 1 | 2009 | 926 | 0.020 |
Why?
|
Hypertrophy | 1 | 2003 | 62 | 0.020 |
Why?
|
Postoperative Complications | 1 | 1994 | 2183 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 1994 | 6481 | 0.010 |
Why?
|
Glucose Oxidase | 1 | 2003 | 7 | 0.010 |
Why?
|
Hexosaminidases | 1 | 1983 | 7 | 0.010 |
Why?
|
Acetylglucosaminidase | 1 | 1983 | 5 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 66 | 0.010 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2002 | 41 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 187 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 53 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2002 | 71 | 0.010 |
Why?
|
Bryostatins | 1 | 2002 | 15 | 0.010 |
Why?
|
Oxidants | 1 | 2003 | 86 | 0.010 |
Why?
|
Cell Fractionation | 1 | 2002 | 71 | 0.010 |
Why?
|
Lactones | 1 | 2002 | 28 | 0.010 |
Why?
|
Macrolides | 1 | 2002 | 31 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2002 | 25 | 0.010 |
Why?
|
Microsomes | 1 | 1982 | 35 | 0.010 |
Why?
|
Cell-Free System | 1 | 1982 | 51 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2008 | 738 | 0.010 |
Why?
|
Rats, Mutant Strains | 1 | 2001 | 23 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2001 | 79 | 0.010 |
Why?
|
Hamartoma | 1 | 2001 | 31 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2001 | 85 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2001 | 86 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 177 | 0.010 |
Why?
|
Insect Proteins | 1 | 2001 | 88 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1980 | 101 | 0.010 |
Why?
|
Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2000 | 5 | 0.010 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2000 | 6 | 0.010 |
Why?
|
Protein Precursors | 1 | 1980 | 143 | 0.010 |
Why?
|
Biotin | 1 | 2000 | 44 | 0.010 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2000 | 55 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 5961 | 0.010 |
Why?
|
Onium Compounds | 1 | 1999 | 4 | 0.010 |
Why?
|
Extracellular Space | 1 | 2000 | 90 | 0.010 |
Why?
|
rac GTP-Binding Proteins | 1 | 1999 | 25 | 0.010 |
Why?
|
Luciferases | 1 | 1999 | 118 | 0.010 |
Why?
|
United States | 1 | 2011 | 6637 | 0.010 |
Why?
|
GTP Phosphohydrolases | 1 | 1999 | 71 | 0.010 |
Why?
|
Carmustine | 1 | 1999 | 70 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2000 | 253 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 2267 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1998 | 104 | 0.010 |
Why?
|
bcl-X Protein | 1 | 1998 | 52 | 0.010 |
Why?
|
Microglia | 1 | 1998 | 102 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 1999 | 138 | 0.010 |
Why?
|
Cell Death | 1 | 1999 | 256 | 0.010 |
Why?
|
S Phase | 1 | 1997 | 62 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1997 | 155 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 377 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2001 | 425 | 0.010 |
Why?
|
DNA Repair | 1 | 1999 | 356 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1999 | 893 | 0.010 |
Why?
|
WT1 Proteins | 1 | 1995 | 19 | 0.010 |
Why?
|
Asthma | 1 | 2003 | 947 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2000 | 584 | 0.010 |
Why?
|
Early Growth Response Protein 1 | 1 | 1995 | 54 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2001 | 620 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1994 | 29 | 0.010 |
Why?
|
Osteosarcoma | 1 | 1995 | 158 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1995 | 201 | 0.010 |
Why?
|
Leukemia, Radiation-Induced | 1 | 1992 | 14 | 0.010 |
Why?
|
CD3 Complex | 1 | 1993 | 135 | 0.010 |
Why?
|
Dexamethasone | 1 | 1994 | 326 | 0.010 |
Why?
|
Virus Activation | 1 | 1992 | 41 | 0.010 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 1992 | 27 | 0.010 |
Why?
|
Mammals | 1 | 1994 | 227 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1991 | 72 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1991 | 74 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1993 | 272 | 0.010 |
Why?
|
Apgar Score | 1 | 1989 | 13 | 0.010 |
Why?
|
Infant, Small for Gestational Age | 1 | 1989 | 28 | 0.010 |
Why?
|
Nerve Crush | 1 | 1989 | 1 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 1989 | 58 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 1989 | 49 | 0.010 |
Why?
|
Obstetric Labor, Premature | 1 | 1989 | 58 | 0.010 |
Why?
|
Lasers | 1 | 1989 | 104 | 0.010 |
Why?
|
Psychotropic Drugs | 1 | 1989 | 75 | 0.010 |
Why?
|
Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1983 | 7 | 0.000 |
Why?
|
Carbohydrate Metabolism | 1 | 1983 | 30 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1989 | 2369 | 0.000 |
Why?
|
Pregnancy | 1 | 1989 | 2885 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1987 | 1376 | 0.000 |
Why?
|